Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Dec 15;13(12):4482.
doi: 10.3390/nu13124482.

Impact of Obesity in Kidney Diseases

Vasilios Kotsis  1 , Fernando Martinez  2 , Christina Trakatelli  1 , Josep Redon  2   3   4
Affiliations
Review

Impact of Obesity in Kidney Diseases

Vasilios Kotsis et al. Nutrients. .

Abstract

The clinical consequences of obesity on the kidneys, with or without metabolic abnormalities, involve both renal function and structures. The mechanisms linking obesity and renal damage are well understood, including several effector mechanisms with interconnected pathways. Higher prevalence of urinary albumin excretion, sub-nephrotic syndrome, nephrolithiasis, increased risk of developing CKD, and progression to ESKD have been identified as being associated with obesity and having a relevant clinical impact. Moreover, renal replacement therapy and kidney transplantation are also influenced by obesity. Losing weight is key in limiting the impact that obesity produces on the kidneys by reducing albuminuria/proteinuria, declining rate of eGFR deterioration, delaying the development of CKD and ESKD, and improving the outcome of a renal transplant. Weight reduction may also contribute to appropriate control of cardiometabolic risk factors such as hypertension, metabolic syndrome, diabetes, and dyslipidemia which may be protective not only in renal damage but also cardiovascular disease. Lifestyle changes, some drugs, and bariatric surgery have demonstrated the benefits.

Keywords: CKD; ESRD; bariatric surgery; fatty kidney; glomerulopathy; obesity.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Mechanisms of obesity induced renal damage. Modified from Kotsis V et al., J Hypertens. 2018 Jul; 36(7):1427–1440.
Figure 2
Figure 2
Obesity-associated structural lesions and functional disorders. FSGS: focal segmentary glomerulosclerosis.
See this image and copyright information in PMC

References

    1. Go A.S., Chertow G.M., Fan D., McCulloch C.E., Hsu C.-Y. Chronic Kidney Disease and the Risks of Death, Cardiovascular Events, and Hospitalization. N. Engl. J. Med. 2004;351:1296–1305. doi: 10.1056/NEJMoa041031. - DOI - PubMed
    1. Matsushita K., Van Der Velde M., Astor B.C., Woodward M., Levey A.S., De Jong P.E., Coresh J., Gansevoort R.T. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: A collaborative meta-analysis. Lancet. 2010;375:2073–2081. doi: 10.1016/s0140-6736(10)60674-5. - DOI - PMC - PubMed
    1. Nitsch D., Grams M., Sang Y., Black C., Cirillo M., Djurdjev O., Iseki K., Jassal S.K., Kimm H., Kronenberg F., et al. Associations of estimated glomerular filtration rate and albuminuria with mortality and renal failure by sex: A meta-analysis. BMJ. 2013;346:f324. doi: 10.1136/bmj.f324. - DOI - PMC - PubMed
    1. Murphy D., McCulloch C.E., Lin F., Banerjee T., Bragg-Gresham J.L., Eberhardt M.S., Morgenstern H., Pavkov M.E., Saran R., Powe N.R., et al. Trends in Prevalence of Chronic Kidney Disease in the United States. Ann. Intern. Med. 2016;165:473–481. doi: 10.7326/M16-0273. - DOI - PMC - PubMed
    1. Hounkpatin H.O., Harris S., Fraser S.D.S., Day J., Mindell J.S., Taal M.W., O’Donoghue D., Roderick P.J. Prevalence of chronic kidney disease in adults in England: Comparison of nationally representative cross-sectional surveys from 2003 to 2016. BMJ Open. 2020;10:e038423. doi: 10.1136/bmjopen-2020-038423. - DOI - PMC - PubMed